{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T03:40:01Z","timestamp":1773718801080,"version":"3.50.1"},"reference-count":23,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":31,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82301527"],"award-info":[{"award-number":["No. 82301527"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Interdisciplinary Program of Shanghai Jiao Tong University","award":["No. YG2023LC04"],"award-info":[{"award-number":["No. YG2023LC04"]}]},{"name":"The Municipal Commission of Health and Family Planning Foundation of Shanghai Pudong New Area","award":["No. PW2022E-01"],"award-info":[{"award-number":["No. PW2022E-01"]}]},{"name":"New Quality Clinical Specialties of High-end Medical Disciplinary Construction in Pudong New Area","award":["No. 2024-PWXZ-16"],"award-info":[{"award-number":["No. 2024-PWXZ-16"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Neurol Open"],"accepted":{"date-parts":[[2025,7,18]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Myasthenia gravis (MG), an IgG-mediated autoimmune disorder targeting neuromuscular junctions, shows refractory in 12\u201320% of generalised MG (gMG) patients despite immunotherapies. Plasma exchange (PLEX) transiently depletes pathogenic mediators, while neonatal Fc receptor antagonists (eg, efgartigimod) offer novel therapeutic potential. Both PLEX and efgartigimod require adjunctive non-steroidal immunosuppressive therapy (NSIST) for sustained remission. This study aims to evaluate the effectiveness and safety of efgartigimod working as a bridge treatment after PLEX but before NSIST taking effect, while concurrently conducting a comparative analysis of clinical outcomes between PLEX and efgartigimod in gMG.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>This multicentre, open-label, three-arm trial (n=45\u2009gMG patients) assigns cohorts to PLEX+efgartigimod, PLEX alone or efgartigimod alone. The intervention comprises PLEX and\/or efgartigimod. Oral glucocorticoids and cholinesterase inhibitors are allowed during this study. NSIST starts the day after completing PLEX or the second dose of efgartigimod. Outcomes are assessed at weeks 4, 8, 12, 16, 20, 24, 36 and 48. Primary endpoint: proportion achieving minimal symptom expression (MSE) at week 48. Secondary endpoints: median time to first MSE, adverse events (AE) incidence\/severity, exacerbation rates, neurological functional assessment scores, cholinesterase inhibitor\/corticosteroid usage, serological evolution of immunological markers. All AEs are systematically documented and causality-assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>Ethical clearance for this investigation was granted by the Institutional Review Board of Punan Hospital in accordance with Declaration of Helsinki principles. All enrolled participants will provide written informed consent through standardised documentation processes prior to study enrolment. The results will be accessible in peer-reviewed publications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration number<\/jats:title>\n                  <jats:p>ChiCTR2500104662.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjno-2025-001180","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:40:20Z","timestamp":1754268020000},"page":"e001180","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Efgartigimod following plasma exchange in the treatment of subjects with generalised myasthenia gravis: study protocol for a multicentre, three-arm, open-label study"],"prefix":"10.1136","volume":"7","clinical-trial-number":[{"clinical-trial-number":"nct03669588","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9811-4142","authenticated-orcid":false,"given":"Kan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"},{"name":"Department of Neurology, Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine (Punan Hospital in Pudong New District, Shanghai), Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4348-3979","authenticated-orcid":false,"given":"Qiuju","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine (Punan Hospital in Pudong New District, Shanghai), Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1623-7335","authenticated-orcid":false,"given":"Yanan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Anhui NO.2 Provincial People's Hospital, Hefei, Anhui, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1115-5129","authenticated-orcid":false,"given":"Mengze","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0402-9452","authenticated-orcid":false,"given":"Xiaokun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4213-7542","authenticated-orcid":false,"given":"Jing","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9604-5921","authenticated-orcid":false,"given":"Chong","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-1843","authenticated-orcid":false,"given":"Chunran","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-0246","authenticated-orcid":false,"given":"Song","family":"Gao","sequence":"additional","affiliation":[{"name":"Heqing Community Health Service Center, Pudong New Area, Shanghai, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3606-4837","authenticated-orcid":false,"given":"Li","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0010-1050","authenticated-orcid":false,"given":"Yiwei","family":"Yang","sequence":"additional","affiliation":[{"name":"Hangzhou Dian Medical Laboratory Co., Ltd, Hangzhou, Zhejiang, China"},{"name":"Zhejiang Key Laboratory of Digital Technology in Medical Diagnostics, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8025-6724","authenticated-orcid":false,"given":"Yuhui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine (Punan Hospital in Pudong New District, Shanghai), Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9929-5420","authenticated-orcid":false,"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Anhui NO.2 Provincial People's Hospital, Hefei, Anhui, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3652-0449","authenticated-orcid":false,"given":"Yong","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China"},{"name":"Department of Neurology, Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine (Punan Hospital in Pudong New District, Shanghai), Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7322-6842","authenticated-orcid":false,"given":"Yangtai","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Punan Branch of Renji Hospital, Shanghai Jiaotong University School of Medicine (Punan Hospital in Pudong New District, Shanghai), Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,8,3]]},"reference":[{"key":"2025080317401440000_7.2.e001180.1","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2021-326480","article-title":"Using AChR antibody titres to predict treatment responses in myasthenia gravis","volume":"92","author":"Vincent","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2025080317401440000_7.2.e001180.2","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1016\/j.cell.2025.03.004","article-title":"Autoimmune mechanisms elucidated through muscle acetylcholine receptor structures","volume":"188","author":"Li","year":"2025","journal-title":"Cell"},{"key":"2025080317401440000_7.2.e001180.3","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/s41586-024-07774-6","article-title":"Structural switch in acetylcholine receptors in developing muscle","volume":"632","author":"Li","year":"2024","journal-title":"Nature New Biol"},{"key":"2025080317401440000_7.2.e001180.4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2025080317401440000_7.2.e001180.5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70063-8"},{"key":"2025080317401440000_7.2.e001180.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00145-3"},{"key":"2025080317401440000_7.2.e001180.7","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/ene.14675","article-title":"Performance of different criteria for refractory myasthenia gravis","volume":"28","author":"Tran","year":"2021","journal-title":"Eur J Neurol"},{"key":"2025080317401440000_7.2.e001180.8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41582-018-0110-z","article-title":"Immunotherapy in myasthenia gravis in the era of biologics","volume":"15","author":"Dalakas","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"2025080317401440000_7.2.e001180.9","doi-asserted-by":"publisher","DOI":"10.1002\/jca.22043"},{"key":"2025080317401440000_7.2.e001180.10","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1002\/acn3.50901","article-title":"Clinical outcome measures following plasma exchange for MG exacerbation","volume":"6","author":"Raja","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"2025080317401440000_7.2.e001180.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.011"},{"key":"2025080317401440000_7.2.e001180.12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/jca.21923","article-title":"Clinical experience with maintenance therapeutic plasma exchange in refractory generalized myasthenia gravis","volume":"36","author":"Sheckley","year":"2021","journal-title":"J Clin Apher"},{"key":"2025080317401440000_7.2.e001180.13","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","article-title":"Remission of myasthenia gravis following plasma-exchange","volume":"2","author":"Pinching","year":"1976","journal-title":"Lancet"},{"key":"2025080317401440000_7.2.e001180.14","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.jocn.2013.11.046","article-title":"Double filtration plasmapheresis benefits myasthenia gravis patients through an immunomodulatory action","volume":"21","author":"Zhang","year":"2014","journal-title":"J Clin Neurosci"},{"key":"2025080317401440000_7.2.e001180.15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/jca.21755","article-title":"Therapeutic plasma exchange may adjust IL-6 and TGF-\u03b2 signals in relapsed MS patients peripheral blood","volume":"35","author":"Jamshidian","year":"2020","journal-title":"J Clin Apher"},{"key":"2025080317401440000_7.2.e001180.16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1007\/s11481-021-10004-9","article-title":"The Role of Plasma Exchange in the Treatment of Refractory Autoimmune Neurological Diseases: a Narrative Review","volume":"16","author":"Jacob","year":"2021","journal-title":"J Neuroimmune Pharmacol"},{"key":"2025080317401440000_7.2.e001180.17","doi-asserted-by":"publisher","DOI":"10.1016\/s1474-4422(21)00159-9"},{"key":"2025080317401440000_7.2.e001180.18","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1284444","article-title":"Long-term safety, tolerability, and efficacy of efgartigimod (ADAPT+): interim results from a phase 3 open-label extension study in participants with generalized myasthenia gravis","volume":"14","author":"Howard","year":"2023","journal-title":"Front Neurol"},{"key":"2025080317401440000_7.2.e001180.19","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025080317401440000_7.2.e001180.20","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179742","article-title":"Myasthenia gravis: the future is here","volume":"134","author":"Kaminski","year":"2024","journal-title":"J Clin Invest"},{"key":"2025080317401440000_7.2.e001180.21","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-025-12922-7","article-title":"Myasthenia gravis in 2025: five new things and four hopes for the future","volume":"272","author":"Binks","year":"2025","journal-title":"J Neurol"},{"key":"2025080317401440000_7.2.e001180.22","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mus.27832","article-title":"Myasthenic crisis","volume":"68","author":"Claytor","year":"2023","journal-title":"Muscle Nerve"},{"key":"2025080317401440000_7.2.e001180.23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: Executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology (ECronicon)"}],"container-title":["BMJ Neurology Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjno-2025-001180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:40:23Z","timestamp":1754268023000},"score":1,"resource":{"primary":{"URL":"https:\/\/neurologyopen.bmj.com\/lookup\/doi\/10.1136\/bmjno-2025-001180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8,3]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/bmjno-2025-001180"],"URL":"https:\/\/doi.org\/10.1136\/bmjno-2025-001180","relation":{},"ISSN":["2632-6140"],"issn-type":[{"value":"2632-6140","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}